Dan McKees fiscal year 2027 budget suggests
"Try and check that your doctor is registered with the General Medical Council, that your pharmacy is registered, if you have any concerns always go and talk to your GP." She added that a collaborative approach was needed to tackle obesity
Although no clinical trials have yet examined their combined use, their complementary mechanisms suggest a potential for synergy

However, after stopping AOM, weight regains due to the compensatory metabolic adjustments described above ( Metformin, a biguanide anti-hyperglycemic agent, is the first-line treatment for type 2 diabetes ( In the Diabetes Prevention Program Outcome Study, modest weight loss with metformin was maintained over a 10-year follow-up period, in contrast to the original lifestyle group from Diabetes Prevention Program, which partly regained weight during follow up period ( Based on its mode of action and some clinical data ( 2 Materials and methods 2.1 Trial design We conducted an observational study including women with PCOS and obesity, followed up at the outpatient clinics of the Department of Endocrinology, Diabetes, and Metabolic Diseases at the University Medical Centre Ljubljana, who continued treatment with metformin 2 years after discontinuation of short-term intervention with semaglutide as an add on to metformin therapy